MaaT Pharma's market cap is currently €61.86M. The company's EPS TTM is €-0.998; its P/E ratio is ―; MaaT Pharma is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
